Abstract
Purpose
The purpose of this study is to evaluate the clinical results of 23-gauge sutureless vitrectomy.
Methods
We retrospectively analyzed 111 eyes that had undergone 23-gauge sutureless vitrectomy. The eyes underwent surgery from February 2006 to July 2006 and were examined for surgical outcome as well as intraoperative and postoperative complications.
Results
The preoperative best corrected visual acuity (BCVA) was 1.43±0.12 and increased to 0.88±0.11 ( P>0.01). Thirteen (11.7%) of 111 eyes developed intraoperative complications, and 21 (18.9%) of 111 eyes developed postoperative complications. Intraoperative complications included wound‐ leaking (seven eyes), conjunctival suture (three eyes), and difficult insertion (two eyes). Postoperative complications included postoperative hypotony (seven eyes), vitreous hemorrhage (seven eyes), hyphema (five eyes), and infectious endophthalmitis (two eyes).
References
1. Machemer R, Buettner H, Norton EW, Parel JM. Vitrectomy: a pars plana approach. Trans Am Acad Ophthalmol Otolaryngol. 1971; 75:813–20.
2. O’Malley, Heintz RM Sr. Vitrectomy with alternative instrument system. Ann Ophthalmol. 1975; 7:585-8–591-4.
3. Chen JC. Sutureless pars plana Vitrectomy through self-sealing sclerotomies. Arch Ophthalmol. 1996; 114:1273–5.
4. Juan E Jr, Hickingbotham D.Refinements in microinstrumentation for vitreous surgery. Am J Ophthalmol. 1990; 109:218–220.
5. Fujii GY, Juan E Jr, Humayun MA. . A new 23-guage instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology. 2002; 109:1814–20.
7. James FW, Zdenek JG. Fibrovascular ingrowth and recurrent haemorrhage following diabetic vitrectomy. Br J Ophthalmol. 2000; 84:822–5.
8. Eifrig CW, Scott IU, Flynn HW Jr. . Endophthalmitis after pars plana vitrectomy: Incidence, causative organisms, and visual acuity outcomes. Am J Ophthalmol. 2004; 138:799–802.
9. Stephen JR. Retina. 4th ed. Vol. 3. Baltimore: Mosby;2006; 2645–54.
10. Rai P. Lauande-Pimentel R, Barton K. Amniotic membrane as an adjunct to donor sclera in the repair of exposed glaucoma drainage devices. Am J Ophthalmol. 2005; 140:1148–52.
Table 1.
Preoperative diagnosis | No. of eyes (%) |
---|---|
PDR* | 44 (39.6) |
Epiretinal membrane | 19 (17.1) |
Macular hole | 18 (16.2) |
Vitreous hemorrhage due to RVO† | 16 (14.4) |
Rhegmatogenous retinal detachment | 4 (3.6) |
PDR with RVO | 3 (2.7) |
Vitreous hemorrhage due to ARMD | 2 (1.8) |
VMT‡ syndrome | 2 (1.8) |
Lens material dislocation to vitreous | 1 (0.9) |
Vitreous opacity due to uveitis | 1 (0.9) |
Secondary glaucoma due to IVTA§ |
1 (0.9) |
Total | 111 (100) |
Table 2.
Combined procedure | No. of eyes (%) |
---|---|
Air fluid exchange | 44 (39.6) |
Phacoemulsification | 7 (6.3) |
Silicone oil injection |
2 (1.8) |
Total | 53 (47.7) |
Table 3.
Intraocular pressure change | |
---|---|
Preoperative | 12.76±3.19 mmHg |
Postoperative 1 day | 12.50±6.11 mmHg* |
Postoperative 15 day | 13.36±5.28 mmHg* |
Table 4.
Complications | No. of eyes (%) |
---|---|
Scleral suture due to leaking | 8 (7.2) |
Conjunctival suture | 3 (2.7) |
Difficulty insertion | 2 (1.8) |
Postoperative hypotony* | 7 (6.3) |
Vitreous hemorrhage | 7 (6.3) |
Hyphema | 5 (4.5) |
Endophthalmitis |
2 (1.8) |
Total | 34 (30.6) |
Table 5.
Leaking cases | Operative procedures | Location |
---|---|---|
ERM | V MP | P2* |
ERM | V MP EL | P3† |
PDR, TRD | V MP EL FGE | P2 |
PDR | V MP EL FGE SOI | P2 |
PDR, TRD | V MP EL FGE SOI | P2 |
PDR, VH | V MP EL FGE | P3 |
PDR | V MP EL | P3 |
PDR, TRD | V MP IVTA | P3 |